2 documents found, page 1 of 1
Efficiency of the EmERGE Pathway of Care in Five European HIV Centres
Beck, EJ; Mandalia, S; Yfantopoulos, P; Leon, A; Merino, MJ; Garcia, F; Wittevogel, M; Apers, L; Benkovic, I; Zekan, S; Begovac, J; Cunha, ASObjective: We aimed to calculate the efficiency of the EmERGE Pathway of Care in five European HIV clinics, developed and implemented for medically stable people living with HIV. Methods: Participants were followed up for 1 year before and after implementation of EmERGE, between April 2016 and October 2019. Micro-costing studies were performed in the outpatient services of the clinics. Unit costs for outpatient...
The Demise of Multidrug-Resistant HIV-1: the National Time Trend in Portugal
Vercauteren, J; Theys, K; Carvalho, AP; Valadas, E; Duque, LM; Teófilo, E; Faria, T; Faria, D; Vera, J; Aguas, MJ; Peres, S; Mansinho, K; Vandamme, AMOBJECTIVES: Despite a decreasing mortality and morbidity in treated HIV-1 patients, highly active antiretroviral treatment (HAART) can still fail due to the development of drug resistance. Especially, multidrug-resistant viruses pose a threat to efficient therapy. We studied the changing prevalence of multidrug resistance (MDR) over time in a cohort of HIV-1-infected patients in Portugal. PATIENTS AND METHODS: ...